Search research articles
Contact Us
Filters
Showing results (101-110 of 117) with videos related to
Page
of 12
Sort By:
European Archives of Psychiatry and Clinical Neuroscience
|
March 24, 2012
Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients
Andrea Schmitt, Fernando Leonardi-Essmann, Pascal F Durrenberger, et al.
Journal of Clinical Psychology
|
January 19, 2022
Association of impulsivity with quality of life and well-being after alcohol withdrawal treatment
Daniela Reichl, Niklas Enewoldsen, Kiona K Weisel, et al.
Substance Use & Misuse
|
February 10, 2022
Lower Emotion Regulation Competencies Mediate the Association between Impulsivity and Craving during Alcohol Withdrawal Treatment
Daniela Reichl, Niklas Enewoldsen, Kiona K Weisel, et al.
Early Intervention in Psychiatry
|
March 27, 2015
Clinical high risk for psychosis: gender differences in symptoms and social functioning
Liz Rietschel, Martin Lambert, Anne Karow, et al.
Schizophrenia Research
|
July 10, 2024
Identifying differential predictors for treatment response to amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia: Results of the COMBINE-study
Viktoria Galuba, Joachim Cordes, Sandra Feyerabend, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2016
Dynamic brain network reconfiguration as a potential schizophrenia genetic risk mechanism modulated by NMDA receptor function
Urs Braun, Axel Schäfer, Danielle S Bassett, et al.
Psychotherapy and Psychosomatics
|
May 25, 2025
Evaluation of a Smartphone App Intervention with Telephone Guidance as Transitional Support from Inpatient Treatment to Continuing Care for Individuals with Alcohol Use Disorder: Results from a Randomized Controlled Trial
Sebastian Saur, Kiona K Weisel, Catharina Lang, et al.
Schizophrenia Bulletin
|
April 6, 2023
Prevention of First-Episode Psychosis in People at Clinical High Risk: A Randomized Controlled, Multicentre Trial Comparing Cognitive-Behavioral Therapy and Clinical Management Plus Low-Dose Aripiprazole or Placebo (PREVENT)
Andreas Bechdolf, Hendrik Müller, Martin Hellmich, et al.
The Lancet. Psychiatry
|
March 11, 2022
Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial
Christian Schmidt-Kraepelin, Sandra Feyerabend, Christina Engelke, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
September 6, 2019
A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design
Christian Schmidt-Kraepelin, Sandra Feyerabend, Christina Engelke, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 117) with videos related to
Sort By:
Page
of 12
European Archives of Psychiatry and Clinical Neuroscience
|
March 24, 2012
Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients
Andrea Schmitt, Fernando Leonardi-Essmann, Pascal F Durrenberger, et al.
Journal of Clinical Psychology
|
January 19, 2022
Association of impulsivity with quality of life and well-being after alcohol withdrawal treatment
Daniela Reichl, Niklas Enewoldsen, Kiona K Weisel, et al.
Substance Use & Misuse
|
February 10, 2022
Lower Emotion Regulation Competencies Mediate the Association between Impulsivity and Craving during Alcohol Withdrawal Treatment
Daniela Reichl, Niklas Enewoldsen, Kiona K Weisel, et al.
Early Intervention in Psychiatry
|
March 27, 2015
Clinical high risk for psychosis: gender differences in symptoms and social functioning
Liz Rietschel, Martin Lambert, Anne Karow, et al.
Schizophrenia Research
|
July 10, 2024
Identifying differential predictors for treatment response to amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia: Results of the COMBINE-study
Viktoria Galuba, Joachim Cordes, Sandra Feyerabend, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2016
Dynamic brain network reconfiguration as a potential schizophrenia genetic risk mechanism modulated by NMDA receptor function
Urs Braun, Axel Schäfer, Danielle S Bassett, et al.
Psychotherapy and Psychosomatics
|
May 25, 2025
Evaluation of a Smartphone App Intervention with Telephone Guidance as Transitional Support from Inpatient Treatment to Continuing Care for Individuals with Alcohol Use Disorder: Results from a Randomized Controlled Trial
Sebastian Saur, Kiona K Weisel, Catharina Lang, et al.
Schizophrenia Bulletin
|
April 6, 2023
Prevention of First-Episode Psychosis in People at Clinical High Risk: A Randomized Controlled, Multicentre Trial Comparing Cognitive-Behavioral Therapy and Clinical Management Plus Low-Dose Aripiprazole or Placebo (PREVENT)
Andreas Bechdolf, Hendrik Müller, Martin Hellmich, et al.
The Lancet. Psychiatry
|
March 11, 2022
Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial
Christian Schmidt-Kraepelin, Sandra Feyerabend, Christina Engelke, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
September 6, 2019
A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design
Christian Schmidt-Kraepelin, Sandra Feyerabend, Christina Engelke, et al.
Page
of 12